{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:48:32Z","timestamp":1785786512387,"version":"3.56.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis is a rare autoimmune disease divided into two subtypes, anti-AMPAR1 encephalitis and anti-AMPAR2 encephalitis, depending on the presence of autoantibodies targeting the GluR1 and GluR2 subunits of the AMPA receptor. The main manifestations are limbic encephalitis, including cognitive impairment, seizures, and psychiatric symptoms. The reported cases of anti-AMPAR encephalitis have grown; however, no research has yet described the clinical characteristics of each subtype. Herein, we present a case of a middle-aged woman with anti-AMPAR2 encephalitis who was admitted to the hospital with sudden-onset seizures. The physical examination did not show noteworthy findings, but the auxiliary examination revealed abnormalities in the temporal lobe. On the third day of her hospitalization, she experienced olfactory hallucinations. AMPAR2 antibodies were detected positive in both serum and cerebrospinal fluid (CSF). After receiving a combination of glucocorticoids and intravenous immunoglobulin (IVIG) treatment, the patient was discharged with improved symptoms. She maintained her regimen of oral prednisone and gradually reduced the dosage following her discharge from the hospital. After 6 months, she was readmitted to the hospital due to a headache and a positive IgG test for serum AMPAR2 antibodies. The patient\u2019s symptoms resolved with glucocorticoid treatment. Additionally, we conducted a literature review and gathered data from 37 individuals with anti-AMPAR2 encephalitis, including our present case. The patients had different levels of AMPAR2 antibodies in their CSF or serum, and some also had other antibodies. There were 23 female and 14 male patients, with a median age of 47 years. Of the patients, 19 (51%) had a history of tumors. The predominant clinical symptoms were memory impairment (78%) and psychobehavioral abnormalities (70%), with other symptoms such as epilepsy, disorders of consciousness, disorientation, hallucinations, dyskinesia, sleep disorders, and cerebellar signs. Most patients exhibited abnormalities on cerebral magnetic resonance imaging (MRI), electroencephalogram (ECG), and CSF examination. Therapeutic interventions such as steroids, IVIg, plasma exchange, or immunosuppressants led to symptom alleviation in the majority of patients. Nevertheless, some patients did not exhibit notable progress or died. This report summarized the clinical features of patients with anti-AMPAR2 encephalitis and discussed its pathogenesis to facilitate early recognition and management.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1444053","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:39:48Z","timestamp":1740033588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 2 encephalitis with olfactory hallucination: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Xuyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103118","DOI":"10.1016\/j.autrev.2022.103118","article-title":"Rare antibody-mediated and seronegative autoimmune encephalitis: An update","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.v10.3","article-title":"Limbic encephalitis associated with AMPA receptor and CRMP5 antibodies: A case report and literature review","volume":"10","author":"Jia","year":"2020","journal-title":"Brain Behav"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9153-8","article-title":"Patient characteristics and outcome associations in AMPA receptor encephalitis","volume":"266","author":"Laurido-Soto","year":"2019","journal-title":"J Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000515592","article-title":"The peculiar clinical symptoms and treatment of limbic encephalitis associated with AMPA receptor antibody","volume":"84","author":"Jia","year":"2021","journal-title":"Eur Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652820","article-title":"Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: A review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical spectrum of encephalitis associated with antibodies against the \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.23.090506.123516","article-title":"The cell biology of synaptic plasticity: AMPA receptor trafficking","volume":"23","author":"Shepherd","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit gluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003138","article-title":"AMPA receptors: Dynamics and targets of disease","volume":"87","author":"Benarroch","year":"2016","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.05.011","article-title":"Rapid progression and brain atrophy in anti-AMPA receptor encephalitis","volume":"261","author":"Wei","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn101070-20190822-00782","article-title":"Case report of anti-AMPA2 receptor antibody encephalitis after herpes simplex virus encephalitis in child","volume":"36","author":"Yan","year":"2021","journal-title":"Zhonghua shi yong er ke lin chuang za zhi"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-6731.2020.04.018","article-title":"Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor encephalitis complicated with deafness: one case report","volume":"20","author":"Wang","year":"2020","journal-title":"Chin J Contemp Neurol Neurosurgery"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.13406\/j.cnki.cyxb.003244","article-title":"Pancreatic cancer complicated with anti-AMPA2 receptor encephalitis: a case report","volume":"48","author":"Zhai","year":"2023","journal-title":"J Chongqing Med University"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112140-20220601-00502","article-title":"A case of infantile anti-AMPA2 receptor encephalitis","volume":"60","author":"Liao","year":"2022","journal-title":"Zhonghua Er Ke Za Zhi Chin J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50393","article-title":"A case report and literature review on positivity for multiple antibodies: autoimmune encephalitis in focus","volume":"15","author":"Asbeutah","year":"2023","journal-title":"Cureus"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.310087","article-title":"A rare case of wobbly, psychotic patient with frozen eyes - anti-AMPA receptor encephalitis","volume":"69","author":"Ashok","year":"2021","journal-title":"Neurol India"},{"key":"B18","doi-asserted-by":"publisher","first-page":"bcr2018225745","DOI":"10.1136\/bcr-2018-225745","article-title":"Anti-AMPA receptor encephalitis associated with Medullary thyroid cancer","volume":"2018","author":"Samad","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.02.011","article-title":"Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis","volume":"281","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-019-1358-7","article-title":"Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.759559","article-title":"Autoimmune encephalitis with multiple auto-antibodies with concomitant human herpesvirus-7 and ovarian teratoma: A case report","volume":"8","author":"Yang","year":"2021","journal-title":"Front Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.827138","article-title":"Autoimmune encephalitis with psychotic manifestations and cognitive impairment presenting as schizophrenia: case report and literature review","volume":"13","author":"Luo","year":"2022","journal-title":"Front Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1006-7876.2019.11.014","article-title":"A case report of B2 thymoma with anti-a-amino-3-hydroxy-5-methyl-4- isoxazolipropionic acid receptor antibody encephalitis","volume":"52","author":"Wang","year":"2019","journal-title":"Chin J Neurology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.673347","article-title":"Case report: coexistence of anti-AMPA receptor encephalitis and positive biomarkers of alzheimer\u2019s disease","volume":"12","author":"Song","year":"2021","journal-title":"Front Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2022.06.004","article-title":"Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody","volume":"44","author":"Ochiai","year":"2022","journal-title":"Brain Dev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227893","article-title":"Fulminant thymomatous AMPAR-antibody limbic encephalitis with hypertonic coma, bruxism, an isoelectric electroencephalogram and temporal cortical atrophy, with recovery","volume":"12","author":"Urriola","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12883-017-0823-4","article-title":"Hashimoto\u2019s encephalitis associated with AMPAR2 antibodies: a case report","volume":"17","author":"Zhu","year":"2017","journal-title":"BMC Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.813926","article-title":"Immune-mediated cerebellar ataxia associated with neuronal surface antibodies","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12883-022-02747-6","article-title":"Neuropsychiatric lupus erythematosus with neurogenic pulmonary edema and anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor limbic encephalitis: a case report","volume":"22","author":"Li","year":"2022","journal-title":"BMC Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2017.7.issue-9","article-title":"Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: Case report and systematic literature review","volume":"7","author":"Wei","year":"2017","journal-title":"Brain Behav"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-016-2680-0","article-title":"Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies","volume":"37","author":"Yang","year":"2016","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cb3e52","article-title":"Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor","volume":"74","author":"Bataller","year":"2010","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3263718","DOI":"10.1155\/2016\/3263718","article-title":"Small-cell lung cancer with positive anti-NMDAR and anti-AMPAR antibodies paraneoplastic limbic encephalitis","volume":"2016","author":"Boangher","year":"2016","journal-title":"Case Rep Neurol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14568","article-title":"Thymoma-associated autoimmune encephalitis with myasthenia gravis: Case series and literature review","volume":"30","author":"Su","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.735983","article-title":"Recurrent anti-AMPA receptor limbic encephalitis: A case report and literature review","volume":"12","author":"Fang","year":"2021","journal-title":"Front Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.05.008","article-title":"Autoimmune-induced glutamatergic receptor dysfunctions: Conceptual and psychiatric practice implications","volume":"23","author":"Rosenthal-Simons","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691536\/full","article-title":"Limitations of a commercial assay as diagnostic test of autoimmune encephalitis","volume":"12","author":"Ruiz-Garc\u00eda","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1444053\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:39:56Z","timestamp":1740033596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1444053\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2025.1444053"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1444053","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"article-number":"1444053"}}